Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
Authors
Keywords
Pancreatic cancer immunotherapy, BM-MSC exosomes, Galectin 9/dectin 1 axis, Macrophage polarization, Immunogenic cell death
Journal
BIOMATERIALS
Volume 268, Issue -, Pages 120546
Publisher
Elsevier BV
Online
2020-11-23
DOI
10.1016/j.biomaterials.2020.120546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
- (2020) Jia-qiao Fan et al. Molecular Cancer
- Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels
- (2020) Adrian M. Seifert et al. ONCOGENE
- Maleimide–thiol adducts stabilized through stretching
- (2019) Wenmao Huang et al. Nature Chemistry
- NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors
- (2019) Andrea Wang-Gillam et al. EUROPEAN JOURNAL OF CANCER
- Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer
- (2019) Yu Zhou et al. Acta Pharmaceutica Sinica B
- Advances in Biomaterials for Drug Delivery
- (2018) Owen S. Fenton et al. ADVANCED MATERIALS
- Mechanism of recipient cell-dependent differences in exosome uptake
- (2018) Sayo Horibe et al. BMC CANCER
- Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity
- (2018) Lisha Liu et al. Theranostics
- Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
- (2018) Bing Feng et al. ADVANCED MATERIALS
- Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis
- (2017) Helena Costa Verdera et al. JOURNAL OF CONTROLLED RELEASE
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
- (2017) Donnele Daley et al. NATURE MEDICINE
- Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
- (2017) Jianqin Lu et al. Nature Communications
- PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
- (2017) Kostandinos Sideras et al. OncoImmunology
- Extracellular vesicles for drug delivery
- (2016) Pieter Vader et al. ADVANCED DRUG DELIVERY REVIEWS
- Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells
- (2016) S Wen et al. LEUKEMIA
- Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
- (2016) Myung Soo Kim et al. Nanomedicine-Nanotechnology Biology and Medicine
- Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway
- (2016) Yang Wang et al. PLoS One
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases
- (2015) Thanh-Huyen Tran et al. CLINICAL IMMUNOLOGY
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Progression of Pancreatic Cancer
- (2014) Robert W. Cowan et al. CANCER JOURNAL
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Pancreatic cancer stroma: Understanding biology leads to new therapeutic strategies
- (2014) Agnieszka Anna Rucki WORLD JOURNAL OF GASTROENTEROLOGY
- Inflammatory networks and immune surveillance of pancreatic carcinoma
- (2013) Robert H Vonderheide et al. CURRENT OPINION IN IMMUNOLOGY
- Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
- (2013) Jing Jiang et al. PLoS One
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
- (2012) Ronne Wee Yeh Yeo et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells
- (2012) Ayano Kabashima-Niibe et al. CANCER SCIENCE
- Exosome-mediated delivery of siRNA in vitro and in vivo
- (2012) Samir El-Andaloussi et al. Nature Protocols
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started